Metraipolis › archive › dc_a140b83edbf4

Comparative effectiveness of budesonide EC and telitacicept in proteinuria and eGFR trajectories in IgA nephropathy: a retrospective cohort study — Europe PMC PMID:42212126

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42212126
DOI
10.3389/fimmu.2026.1821774
License (as archived)
solo-consultazione
Archived
2026-11-02T07:35:12.054Z
SHA-256 of the archived text
a9c5dce37596bdf5eb2ccf68c9b009e0e1893d43e20f6d6ead61786e9651c78e
Stable URL of this page
https://metraipolis.com/documento/dc_a140b83edbf4

How to cite

Comparative effectiveness of budesonide EC and telitacicept in proteinuria and eGFR trajectories in IgA nephropathy: a retrospective cohort study — Europe PMC PMID:42212126 — Europe PMC (en), https://europepmc.org/article/MED/42212126 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a140b83edbf4 (Metraipolis archive dc_a140b83edbf4, sha256 a9c5dce37596bdf5eb2ccf68c9b009e0e1893d43e20f6d6ead61786e9651c78e)
BibTeX
@misc{dca140b83edbf4,
  title = {Comparative effectiveness of budesonide EC and telitacicept in proteinuria and eGFR trajectories in IgA nephropathy: a retrospective cohort study — Europe PMC PMID:42212126},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42212126},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a140b83edbf4; sha256 a9c5dce37596bdf5eb2ccf68c9b009e0e1893d43e20f6d6ead61786e9651c78e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42212126. Agents can read the archived copy with the MCP tool read_document.